Your browser doesn't support javascript.
loading
Towards consensus in defining and handling contextual factors within rheumatology trials: an initial qualitative study from an OMERACT working group.
Nielsen, Sabrina Mai; Uggen Rasmussen, Marianne; Boers, Maarten; A van der Windt, Danielle; de Wit, Maarten; G Woodworth, Thasia; A Flurey, Caroline; Beaton, Dorcas; Shea, Beverley; Escorpizo, Reuben; Furst, Daniel E; Smolen, Josef S; Toupin-April, Karine; Boonen, Annelies; Voshaar, Marieke; Ellingsen, Torkell; Wells, George A; Reeves, Barnaby C; March, Lyn; Tugwell, Peter; Christensen, Robin.
Afiliação
  • Nielsen SM; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark sabrina.mai.nielsen@regionh.dk.
  • Uggen Rasmussen M; Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Odense, Denmark.
  • Boers M; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark.
  • A van der Windt D; Department of Epidemiology & Data Science; and Amsterdam Rheumatology and Immunology Center, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.
  • de Wit M; School of Medicine; Primary Care Centre Versus Arthritis; and Centre for Prognosis Research, Faculty of Medicine and Health Sciences, Keele University, Keele, Staffordshire, UK.
  • G Woodworth T; OMERACT Patient Research Partner, Amsterdam, The Netherlands.
  • A Flurey C; Division of Rheumatology, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Beaton D; Department of Health and Social Sciences, Faculty of Health and Applied Sciences, University of the West of England, Bristol, UK.
  • Shea B; Institute for Work and Health, and Department of Occupational Science and Occupational Therapy, Rehabilitation Sciences Institute and the Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
  • Escorpizo R; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Furst DE; Department of Rehabilitation and Movement Science, College of Nursing and Health Sciences, University of Vermont, Burlington, Vermont, USA.
  • Smolen JS; Swiss Paraplegic Research, Nottwil, Switzerland.
  • Toupin-April K; Division of Rheumatology, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Boonen A; Division of Rheumatology, University of Washington, Seattle, Washington, USA.
  • Voshaar M; University of Florence, Florence, Italy.
  • Ellingsen T; Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria.
  • Wells GA; Children's Hospital of Eastern Ontario Research Institute; Department of Pediatrics and School of Rehabilitation Sciences, University of Ottawa, Ottawa, Ontario, Canada.
  • Reeves BC; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
  • March L; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.
  • Tugwell P; University of Twente, Enschede, Faculty of Behavioural Management and Social sciences, Department Psychology, Health and Technology, University of Twente, Enschede, The Netherlands.
  • Christensen R; Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Odense, Denmark.
Ann Rheum Dis ; 80(2): 242-249, 2021 02.
Article em En | MEDLINE | ID: mdl-33055082
ABSTRACT

OBJECTIVES:

The Outcome Measures in Rheumatology Initiative established the Contextual Factors Working Group to guide the understanding, identification and handling of contextual factors for clinical trials. In clinical research, different uses of the term 'contextual factors' exist. This study explores the perspectives of researchers (including clinicians) and patients in defining 'contextual factor' and its related terminology, identifying such factors and accounting for them in trials across rheumatology.

METHODS:

We conducted individual semistructured interviews with researchers (including clinicians) who have experience within the field of contextual factors in clinical trials or other potentially relevant areas, and small focus group interviews with patients with rheumatic conditions. We transcribed the interviews and applied qualitative content analysis.

RESULTS:

We interviewed 12 researchers and 7 patients. Researcher's and patient's descriptions of contextual factors were categorised into two broad themes, each comprising two contextual factors types. The 'treatment effect' theme focused on factors explaining variations in treatment effects (A) among patients and (B) among studies. The 'outcome measurement' theme focused on factors that explain (C) variations in the measurement result itself (apart from actual changes/differences in the outcome) and (D) variations in the outcome itself (beside treatment of interest). Methods for identifying and handling contextual factors differed among these themes and types.

CONCLUSIONS:

Two main themes for contextual factors with four types of contextual factors were identified based on input from researchers and patients. This will guide operationalisation of contextual factors. Further research should refine our findings and establish consensus among relevant stakeholders.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pesquisadores / Reumatologia / Ensaios Clínicos como Assunto / Reumatologistas / Terminologia como Assunto Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pesquisadores / Reumatologia / Ensaios Clínicos como Assunto / Reumatologistas / Terminologia como Assunto Idioma: En Ano de publicação: 2021 Tipo de documento: Article